Protocols
2 protocol(s) meet the specified criteria
Drug: ABIRATERONE
Protocol No.TitleStatus
9785-CL-0123A Phase 2 Open-label Extension Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical StudyOpen
A031201-CIRBPHASE III TRIAL OF ENZALUTAMIDE (NSC # 766085) VERSUS ENZALUTAMIDE, ABIRATERONE AND PREDNISONE FOR CASTRATION RESISTANT METASTATIC PROSTATE CANCEROpen (affiliates only)